Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity. (Q53525100)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Chulwoo Ahn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Bong-Soo Cha

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Chulsik Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Jina Park

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Jongsuk Park

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Sungkil Lim

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Kyungrae Kim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Hyunchul Lee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1164-1171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

Arterial Wall Thickness is Associated with Insulin Resistance in Type 2 Diabetic Patients

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Abdominal adiposity and insulin resistance in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Mechanism of insulin resistance in A-ZIP/F-1 fatless mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Diagnosis, prevention, and intervention for the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Current management strategies for coexisting diabetes mellitus and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Effect of fatty acids on glucose production and utilization in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Insulin resistance, inflammation, and the prediabetic state

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Fasting and daylong triglycerides in obesity with and without type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Leptin signaling pathways in the central nervous system: interactions between neuropeptide Y and melanocortins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Obesity-associated activation of angiotensin and endothelin in the cardiovascular system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Association of hypoadiponectinemia with coronary artery disease in men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Low plasma adiponectin levels predict progression of coronary artery calcification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Heterogeneity of pig intestinal D-glucose transport systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Role of Adiponectin in Insulin-Resistant Hypertension and Atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Adiponectin and future coronary heart disease events among men with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Correct homeostasis model assessment (HOMA) evaluation uses the computer program

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Metabolic implications of body fat distribution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Correlation between midthigh low-density muscle and insulin resistance in obese nondiabetic patients in Korea.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

Pancreatic beta-cell loss and preservation in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.133

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16899797%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference